Novel perspectives in the tuberculosis treatment: Administration of isoniazid through the skin
Display Omitted
Autor*in: |
Caon, Thiago [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2015 |
---|
Schlagwörter: |
---|
Umfang: |
8 |
---|
Übergeordnetes Werk: |
Enthalten in: Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides - Nigolian, H. ELSEVIER, 2022, New York, NY [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:494 ; year:2015 ; number:1 ; day:15 ; month:10 ; pages:463-470 ; extent:8 |
Links: |
---|
DOI / URN: |
10.1016/j.ijpharm.2015.08.067 |
---|
Katalog-ID: |
ELV023698594 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV023698594 | ||
003 | DE-627 | ||
005 | 20230623171228.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2015 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijpharm.2015.08.067 |2 doi | |
028 | 5 | 2 | |a GBVA2015013000025.pica |
035 | |a (DE-627)ELV023698594 | ||
035 | |a (ELSEVIER)S0378-5173(15)30164-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.61 |2 bkl | ||
100 | 1 | |a Caon, Thiago |e verfasserin |4 aut | |
245 | 1 | 0 | |a Novel perspectives in the tuberculosis treatment: Administration of isoniazid through the skin |
264 | 1 | |c 2015 | |
300 | |a 8 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Display Omitted | ||
650 | 7 | |a Skin permeation |2 Elsevier | |
650 | 7 | |a Transdermal delivery |2 Elsevier | |
650 | 7 | |a Chemical penetration enhancer |2 Elsevier | |
650 | 7 | |a Isoniazid |2 Elsevier | |
700 | 1 | |a Campos, Carlos Eduardo Maduro |4 oth | |
700 | 1 | |a Simões, Cláudia Maria Oliveira |4 oth | |
700 | 1 | |a Silva, Marcos Antônio Segatto |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Nigolian, H. ELSEVIER |t Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |d 2022 |g New York, NY [u.a.] |w (DE-627)ELV008932840 |
773 | 1 | 8 | |g volume:494 |g year:2015 |g number:1 |g day:15 |g month:10 |g pages:463-470 |g extent:8 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.ijpharm.2015.08.067 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
936 | b | k | |a 44.61 |j Innere Medizin |q VZ |
951 | |a AR | ||
952 | |d 494 |j 2015 |e 1 |b 15 |c 1015 |h 463-470 |g 8 | ||
953 | |2 045F |a 610 |
author_variant |
t c tc |
---|---|
matchkey_str |
caonthiagocamposcarloseduardomadurosimes:2015----:oeprpcieiteueclssramnamnsrtooi |
hierarchy_sort_str |
2015 |
bklnumber |
44.61 |
publishDate |
2015 |
allfields |
10.1016/j.ijpharm.2015.08.067 doi GBVA2015013000025.pica (DE-627)ELV023698594 (ELSEVIER)S0378-5173(15)30164-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Caon, Thiago verfasserin aut Novel perspectives in the tuberculosis treatment: Administration of isoniazid through the skin 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Skin permeation Elsevier Transdermal delivery Elsevier Chemical penetration enhancer Elsevier Isoniazid Elsevier Campos, Carlos Eduardo Maduro oth Simões, Cláudia Maria Oliveira oth Silva, Marcos Antônio Segatto oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:494 year:2015 number:1 day:15 month:10 pages:463-470 extent:8 https://doi.org/10.1016/j.ijpharm.2015.08.067 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 494 2015 1 15 1015 463-470 8 045F 610 |
spelling |
10.1016/j.ijpharm.2015.08.067 doi GBVA2015013000025.pica (DE-627)ELV023698594 (ELSEVIER)S0378-5173(15)30164-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Caon, Thiago verfasserin aut Novel perspectives in the tuberculosis treatment: Administration of isoniazid through the skin 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Skin permeation Elsevier Transdermal delivery Elsevier Chemical penetration enhancer Elsevier Isoniazid Elsevier Campos, Carlos Eduardo Maduro oth Simões, Cláudia Maria Oliveira oth Silva, Marcos Antônio Segatto oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:494 year:2015 number:1 day:15 month:10 pages:463-470 extent:8 https://doi.org/10.1016/j.ijpharm.2015.08.067 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 494 2015 1 15 1015 463-470 8 045F 610 |
allfields_unstemmed |
10.1016/j.ijpharm.2015.08.067 doi GBVA2015013000025.pica (DE-627)ELV023698594 (ELSEVIER)S0378-5173(15)30164-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Caon, Thiago verfasserin aut Novel perspectives in the tuberculosis treatment: Administration of isoniazid through the skin 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Skin permeation Elsevier Transdermal delivery Elsevier Chemical penetration enhancer Elsevier Isoniazid Elsevier Campos, Carlos Eduardo Maduro oth Simões, Cláudia Maria Oliveira oth Silva, Marcos Antônio Segatto oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:494 year:2015 number:1 day:15 month:10 pages:463-470 extent:8 https://doi.org/10.1016/j.ijpharm.2015.08.067 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 494 2015 1 15 1015 463-470 8 045F 610 |
allfieldsGer |
10.1016/j.ijpharm.2015.08.067 doi GBVA2015013000025.pica (DE-627)ELV023698594 (ELSEVIER)S0378-5173(15)30164-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Caon, Thiago verfasserin aut Novel perspectives in the tuberculosis treatment: Administration of isoniazid through the skin 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Skin permeation Elsevier Transdermal delivery Elsevier Chemical penetration enhancer Elsevier Isoniazid Elsevier Campos, Carlos Eduardo Maduro oth Simões, Cláudia Maria Oliveira oth Silva, Marcos Antônio Segatto oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:494 year:2015 number:1 day:15 month:10 pages:463-470 extent:8 https://doi.org/10.1016/j.ijpharm.2015.08.067 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 494 2015 1 15 1015 463-470 8 045F 610 |
allfieldsSound |
10.1016/j.ijpharm.2015.08.067 doi GBVA2015013000025.pica (DE-627)ELV023698594 (ELSEVIER)S0378-5173(15)30164-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Caon, Thiago verfasserin aut Novel perspectives in the tuberculosis treatment: Administration of isoniazid through the skin 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Skin permeation Elsevier Transdermal delivery Elsevier Chemical penetration enhancer Elsevier Isoniazid Elsevier Campos, Carlos Eduardo Maduro oth Simões, Cláudia Maria Oliveira oth Silva, Marcos Antônio Segatto oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:494 year:2015 number:1 day:15 month:10 pages:463-470 extent:8 https://doi.org/10.1016/j.ijpharm.2015.08.067 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 494 2015 1 15 1015 463-470 8 045F 610 |
language |
English |
source |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:494 year:2015 number:1 day:15 month:10 pages:463-470 extent:8 |
sourceStr |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:494 year:2015 number:1 day:15 month:10 pages:463-470 extent:8 |
format_phy_str_mv |
Article |
bklname |
Innere Medizin |
institution |
findex.gbv.de |
topic_facet |
Skin permeation Transdermal delivery Chemical penetration enhancer Isoniazid |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
authorswithroles_txt_mv |
Caon, Thiago @@aut@@ Campos, Carlos Eduardo Maduro @@oth@@ Simões, Cláudia Maria Oliveira @@oth@@ Silva, Marcos Antônio Segatto @@oth@@ |
publishDateDaySort_date |
2015-01-15T00:00:00Z |
hierarchy_top_id |
ELV008932840 |
dewey-sort |
3610 |
id |
ELV023698594 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV023698594</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623171228.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2015.08.067</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015013000025.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV023698594</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(15)30164-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Caon, Thiago</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Novel perspectives in the tuberculosis treatment: Administration of isoniazid through the skin</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Skin permeation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Transdermal delivery</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemical penetration enhancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Isoniazid</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Campos, Carlos Eduardo Maduro</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Simões, Cláudia Maria Oliveira</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Silva, Marcos Antônio Segatto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:494</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:1</subfield><subfield code="g">day:15</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:463-470</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2015.08.067</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">494</subfield><subfield code="j">2015</subfield><subfield code="e">1</subfield><subfield code="b">15</subfield><subfield code="c">1015</subfield><subfield code="h">463-470</subfield><subfield code="g">8</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Caon, Thiago |
spellingShingle |
Caon, Thiago ddc 610 bkl 44.61 Elsevier Skin permeation Elsevier Transdermal delivery Elsevier Chemical penetration enhancer Elsevier Isoniazid Novel perspectives in the tuberculosis treatment: Administration of isoniazid through the skin |
authorStr |
Caon, Thiago |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008932840 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 610 VZ 44.61 bkl Novel perspectives in the tuberculosis treatment: Administration of isoniazid through the skin Skin permeation Elsevier Transdermal delivery Elsevier Chemical penetration enhancer Elsevier Isoniazid Elsevier |
topic |
ddc 610 bkl 44.61 Elsevier Skin permeation Elsevier Transdermal delivery Elsevier Chemical penetration enhancer Elsevier Isoniazid |
topic_unstemmed |
ddc 610 bkl 44.61 Elsevier Skin permeation Elsevier Transdermal delivery Elsevier Chemical penetration enhancer Elsevier Isoniazid |
topic_browse |
ddc 610 bkl 44.61 Elsevier Skin permeation Elsevier Transdermal delivery Elsevier Chemical penetration enhancer Elsevier Isoniazid |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
c e m c cem cemc c m o s cmo cmos m a s s mas mass |
hierarchy_parent_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
hierarchy_parent_id |
ELV008932840 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV008932840 |
title |
Novel perspectives in the tuberculosis treatment: Administration of isoniazid through the skin |
ctrlnum |
(DE-627)ELV023698594 (ELSEVIER)S0378-5173(15)30164-2 |
title_full |
Novel perspectives in the tuberculosis treatment: Administration of isoniazid through the skin |
author_sort |
Caon, Thiago |
journal |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
journalStr |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2015 |
contenttype_str_mv |
zzz |
container_start_page |
463 |
author_browse |
Caon, Thiago |
container_volume |
494 |
physical |
8 |
class |
610 610 DE-600 610 VZ 44.61 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Caon, Thiago |
doi_str_mv |
10.1016/j.ijpharm.2015.08.067 |
dewey-full |
610 |
title_sort |
novel perspectives in the tuberculosis treatment: administration of isoniazid through the skin |
title_auth |
Novel perspectives in the tuberculosis treatment: Administration of isoniazid through the skin |
abstract |
Display Omitted |
abstractGer |
Display Omitted |
abstract_unstemmed |
Display Omitted |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
container_issue |
1 |
title_short |
Novel perspectives in the tuberculosis treatment: Administration of isoniazid through the skin |
url |
https://doi.org/10.1016/j.ijpharm.2015.08.067 |
remote_bool |
true |
author2 |
Campos, Carlos Eduardo Maduro Simões, Cláudia Maria Oliveira Silva, Marcos Antônio Segatto |
author2Str |
Campos, Carlos Eduardo Maduro Simões, Cláudia Maria Oliveira Silva, Marcos Antônio Segatto |
ppnlink |
ELV008932840 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth |
doi_str |
10.1016/j.ijpharm.2015.08.067 |
up_date |
2024-07-06T19:31:20.038Z |
_version_ |
1803859294986174464 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV023698594</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623171228.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2015.08.067</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015013000025.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV023698594</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(15)30164-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Caon, Thiago</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Novel perspectives in the tuberculosis treatment: Administration of isoniazid through the skin</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Skin permeation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Transdermal delivery</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemical penetration enhancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Isoniazid</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Campos, Carlos Eduardo Maduro</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Simões, Cláudia Maria Oliveira</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Silva, Marcos Antônio Segatto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:494</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:1</subfield><subfield code="g">day:15</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:463-470</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2015.08.067</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">494</subfield><subfield code="j">2015</subfield><subfield code="e">1</subfield><subfield code="b">15</subfield><subfield code="c">1015</subfield><subfield code="h">463-470</subfield><subfield code="g">8</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.3968735 |